Summary & Overview
CPT 43198: Flexible Transnasal Esophagoscopy with Biopsy
CPT code 43198 covers a flexible transnasal esophagoscopy with one or more biopsies. This endoscopic diagnostic procedure enables direct visualization of the esophageal mucosa and targeted tissue sampling, which is essential for diagnosing conditions such as esophagitis, Barrett’s esophagus, infection, and malignancy. Nationally, the code is relevant for gastroenterology and otolaryngology practice settings and for payers managing endoscopy benefit policies and utilization.
Key payers included in the analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context, typical settings of care, and the main payers that commonly cover the service. The publication also summarizes benchmarks and policy considerations related to billing and coverage, plus operational factors that influence site-of-service decisions and documentation needs.
This summary is intended for billing managers, clinical leaders, and policy analysts seeking a clear, national-level briefing on how CPT code 43198 is used and assessed across major payers and care settings.
Billing Code Overview
CPT code 43198 describes an esophagoscopy using a flexible endoscope passed through the nose, during which the clinician performs one or more biopsies. The procedure is an endoscopic evaluation of the esophagus with tissue sampling for diagnostic purposes.
-
Service type: Diagnostic endoscopic procedure with biopsy
-
Typical site of service: Ambulatory endoscopy suite or hospital outpatient endoscopy unit
Clinical & Coding Specifications
Clinical Context
A typical patient is a 55-year-old adult referred to an otolaryngologist or gastroenterologist for evaluation of dysphagia, odynophagia, chronic heartburn refractory to medical therapy, or an abnormal barium swallow. The patient undergoes a flexible transnasal esophagoscopy performed in an office or ambulatory endoscopy suite using a slim flexible endoscope introduced through the nasal cavity to visualize the esophageal mucosa. During the visit the provider documents history and focused exam, obtains informed consent, and applies topical nasal anesthesia and decongestant. The procedure includes inspection of the hypopharynx and entire esophageal lumen and obtaining one or more mucosal biopsies for histopathology to evaluate for eosinophilic esophagitis, Barrett esophagus, esophagitis, infection, or malignancy. Post-procedure, the patient is observed briefly, given post-procedure instructions, and specimens are submitted to pathology with appropriate labeling and documentation of number and site of biopsies.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier — default reporting | Use when no distinct modifier applies and standard reporting is required |
11 | Office or other outpatient service (default) |